Innovative Technology Altravax specializes in protein and immunogen optimization utilizing advanced molecular biology techniques, providing opportunities for partnerships or contract research support in biopharmaceutical development projects.
Growing Funding With recent funding of $2 million, Altravax has demonstrated investor confidence, enabling potential expansion of research capabilities and increased collaboration with pharmaceutical and biotech companies.
Niche Focus As a small biotech with a focus on disease prevention and treatment, Altravax offers tailored research services and innovative product development opportunities for organizations seeking specialized partnerships.
Technological Stack Utilizing cloud-based infrastructure and modern web technologies, Altravax shows a commitment to scalable research and secure data management, presenting opportunities for tech partners or service providers.
Market Positioning Positioned within the competitive biotech industry alongside companies like NovaVax and Moderna, Altravax offers flexible, niche research expertise that could appeal to larger firms seeking specialized R&D outsourcing or collaboration.
$500M$1B
$1M$10M
$100M$250M
$1B$10B
$100M$250M
$100M$250M
$50M$100M
$25M$50MAltravax, Inc. uses 8 technology products and services including WordPress, Google Cloud, jQuery, and more. Explore Altravax, Inc.'s tech stack below.
| Altravax, Inc. Email Formats | Percentage |
| First.Last@altravax.com | 50% |
| First.Last@altravax.com | 50% |
Biotechnology ResearchUnited States2-10 Employees
Altravax, Inc. is a privately held biopharmaceutical company with research laboratories and business operations in Sunnyvale, CA. Altravax uses its Protein and Immunogen Optimization Systems to create and improve protein function to prevent and treat disease. Altravax's Acclivity Biosystems division also offers contract research support for partner projects involving directed evolution and other molecular biology methodologies.
Company Overview
Funding & FinancialsAltravax, Inc. has raised a total of $2M of funding over 2 rounds. Their latest funding round was raised on Nov 30, 2009 in the amount of $2M.
Altravax, Inc.'s revenue is estimated to be in the range of $1M$10M
Funding & FinancialsAltravax, Inc. has raised a total of $2M of funding over 2 rounds. Their latest funding round was raised on Nov 30, 2009 in the amount of $2M.
Altravax, Inc.'s revenue is estimated to be in the range of $1M$10M
1-888-653-2347 
support@leadiq.com